title: The additive effects of hepatitis C infection and end-stage renal disease in porphyria cutanea tarda.
abstract: Various factors contribute to the development of porphyria cutanea tarda (PCT). In this case report, we describe a patient with hepatitis C infection and chronic renal failure. The individual mechanisms, which promote cutaneous disease, are discussed. Finally, we propose that each factor may have an additive effect in prolonging the skin lesions of PCT.
authors.affiliation: University of Hawaii, Honolulu, HI, USA.
authors.forename: Owen T M
authors.initials: OT
authors.lastname: Chan
authors.forename: Naoky
authors.initials: N
authors.lastname: Tsai
authors.forename: Ramona L
authors.initials: RL
authors.lastname: Wong
authors.forename: Allan K
authors.initials: AK
authors.lastname: Izumi
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002506:Cephalexin / Q000627:therapeutic use; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D019190:Iron Overload / Q000150:complications / Q000209:etiology / Q000517:prevention & control; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D008875:Middle Aged; D018962:Phlebotomy; D017119:Porphyria Cutanea Tarda / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D014578:Uroporphyrins / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents; D014578:Uroporphyrins; D002506:Cephalexin